Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Net Margin: 2009-2020

Historic Net Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to -28.30%.

  • Avadel Pharmaceuticals' Net Margin rose 48455.00% to 70.34% in Q4 2020 from the same period last year, while for Dec 2020 it was 134.91%, marking a year-over-year increase of 26330.00%. This contributed to the annual value of -28.30% for FY2020, which is 10010.00% up from last year.
  • As of FY2020, Avadel Pharmaceuticals' Net Margin stood at -28.30%, which was up 77.96% from -128.39% recorded in FY2019.
  • Avadel Pharmaceuticals' 5-year Net Margin high stood at 39.41% for FY2017, and its period low was -128.39% during FY2019.
  • Over the past 3 years, Avadel Pharmaceuticals' median Net Margin value was -92.29% (recorded in 2018), while the average stood at -82.99%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by 13,169bps in 2018, then surged by 10,010bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Net Margin (Yearly) stood at -27.47% in 2016, then soared by 6,688bps to 39.41% in 2017, then crashed by 13,169bps to -92.29% in 2018, then crashed by 3,611bps to -128.39% in 2019, then spiked by 10,010bps to -28.30% in 2020.